Betsson AB
LSE:0A37
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Betsson AB
LSE:0A37
|
SE |
|
M
|
MPH Health Care AG
DUS:93M1
|
DE |
|
E
|
Evoke Pharma Inc
F:EV0
|
US |
|
D
|
Domain Holdings Australia Ltd
F:3DH
|
AU |
|
ZoomInfo Technologies Inc
NASDAQ:ZI
|
US |
|
I
|
Invesco Mortgage Capital Inc
F:7M2
|
US |
|
CloudMD Software & Services Inc
XTSX:DOC
|
CA |
Wall St Price Targets
0A37 Price Targets Summary
Betsson AB
According to Wall Street analysts, the average 1-year price target for 0A37 is 108.78 SEK with a low forecast of 95.19 SEK and a high forecast of 125.01 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0A37's stock price target?
Price Target
108.78
SEK
According to Wall Street analysts, the average 1-year price target for 0A37 is 108.78 SEK with a low forecast of 95.19 SEK and a high forecast of 125.01 SEK.
What is the Revenue forecast for Betsson AB?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Betsson AB?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is -5%.
What is the Net Income forecast for Betsson AB?
Projected CAGR
-7%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is -7%.
